
Eton Pharmaceuticals announced it will release its first quarter 2026 financial results on May 14, 2026. The company will host a conference call and live webcast at 4:30 p.m. ET to discuss the results and answer investor questions submitted live and via email. Eton focuses on treatments for rare diseases and currently markets ten products, with four more in late-stage development. This earnings report will provide insights into the company's recent performance and progress in its product pipeline.